Guidance
Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves surgically removing visible cancer and bathing the abdominal cavity with heated chemotherapy fluid to reach any remaining cancer cells.
Is this guidance up to date?
Next review: March 2024
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance.
This guidance replaces previous NICE interventional procedures guidance on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis (IPG331).